Benign Prostatic Hyperplasia (BPH) Drugs Market Size By Regional Analysis(Europe, Asia Pacific, America, Middle East And Africa), By Demand & COVID-19 Impact Analysis, By Type, By Applications And Forecasts 2023 - 2030
Report Overview
The market research report is created with a compilation of analytical research based on historic records, current statistics, and future predictions. The report contains details on the leading players operating in the Benign Prostatic Hyperplasia (BPH) Drugs market including various factors related to and dependent influencing the market growth.
Urology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control problems, kidney stones and prostate problems, among others. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Benign prostatic hyperplasia (BPH) is an enlarged prostate, which increases the size of the prostate gland. As the prostate gets enlarged, it may squeeze or partly block the urethra, resulting in significantly blocking urine flow. BPH is normal in the aging process of a male, caused by changes in hormone balance and cell-growth.
The increasing demand for Benign Prostatic Hyperplasia (BPH) Drugs drives the market. Three factors contributing to the growth of the global benign prostatic hyperplasia drugs market are growing geriatric male population, strong r&d and growing demand for alpha-blockers. The evolution of alpha-blockers therapy for BPH has focused on improving convenience and tolerability. Reversing signs and symptoms or preventing progression of the disease are the indications of treating BPH. Alpha-blockers are the most effective, least costly, and best tolerated of the drugs for relieving LUTS. Additionally, one driver in market is growing geriatric male population. The presence of a large population with BPH symptoms is expected to drive the market growth. The risk of BPH increases exponentially with the rise in the age of an individual. Approximately, 80% of men who reach 60 years and above have mild to strong symptoms of BPH. This disorder affects one in 38 individuals in the age group of 40-59 years; however, in the age group of 60-69 years, it affects one in 14 individuals. The BPH drugs market in the Americas accounted for the majority market share during 2016 and the market in this region is likely to experience a high growth rate during the estimated period. Factors such as the growing demand for urology-related disorders and the increasing rate of geriatric men population, will stimulate the demand for BPH drugs and fuel the market\'s growth.
The global Benign Prostatic Hyperplasia (BPH) Drugs market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2030, growing at a CAGR of xx% during 2023-2030. The objectives of this study are to define, segment, and project the size of the Benign Prostatic Hyperplasia (BPH) Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Benign Prostatic Hyperplasia (BPH) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Benign Prostatic Hyperplasia (BPH) Drugs in these regions.
This research report categorizes the global Benign Prostatic Hyperplasia (BPH) Drugs market by top players/brands, region, type and end user. This report also studies the global Benign Prostatic Hyperplasia (BPH) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The report is prepared using analytical methods such as SWOT (strengths, weaknesses, opportunities, and threats)) analysis, PESTEL Analysis, Porter\'s Five Force Analysis, and value chain analysis. These methods provide a clear view of the market structure and analyze competition at a global level. They also provide detailed information on each segment in the global Benign Prostatic Hyperplasia (BPH) Drugs market.
The aim of the report is to interpret the market sizes of various segments and countries for the forecast period. The study includes the qualitative and quantitative analysis of the market. The report analyses the Benign Prostatic Hyperplasia (BPH) Drugs market on a regional and global level with a deep analysis of macro-and micro-economic factors impacting the growth of the market. This report also includes market information related to the latest industry trends, market developments, and analysis of products and end users contributing to market growth. An in-depth study of the current market scenario, major driving factors, and restraining factors for the market are also included in the report.
The Benign Prostatic Hyperplasia (BPH) Drugs market report includes information related to market segmentation, market size and revenue forecasts, and regional forecasts along with information about the leading market players operating in the market, company revenue shares and, their recent developments. The market is classified regionally on country-level into North America, Europe, Asia Pacific, the Middle East and Africa, and South America.
Scope of the Benign Prostatic Hyperplasia (BPH) Drugs Market:
The major competitors working in the market are:
, Astellas Pharma, Eli Lilly, GlaxoSmithKline, Sanofi, ADC Therapeutics, Bayer HealthCare, Bristol-Myers Squibb, Valeant Pharmaceuticals, Endo Pharmaceuticals, Foresee Pharmaceuticals
Market by Order Type
Alpha-Blocker
Phosphodiesterase Type-5 Inhibitors
5-Alpha-Reductase Inhibitors
Market size by End User
Men
Women
Regions Covered in the Report are:
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Rest of the World
The information about the Benign Prostatic Hyperplasia (BPH) Drugs market is obtained from several sources such as company websites, journals, annual reports, which were then assessed and verified by the industry experts. The information is represented in the form of diagrams, charts, pie charts, and infographics, which helps in a better understanding of the market.
Objectives of Benign Prostatic Hyperplasia (BPH) Drugs Market Report:
- To analyze the factors driving the market growth including supply chain analysis, price analysis along with other analytical methods
- To provide an in-depth analysis of the Benign Prostatic Hyperplasia (BPH) Drugs market with information on various segment and sub-segments
- To provide a regional analysis and global analysis for the Benign Prostatic Hyperplasia (BPH) Drugs market size and their forecasts
- To provide strategic profiles of the key players operating in the Benign Prostatic Hyperplasia (BPH) Drugs market, their key competencies, and market competition
- To provide a competitive scenario about the key factors driving, restraining, and challenging the market growth.
- The impact of COVID-19 pandemic on the Benign Prostatic Hyperplasia (BPH) Drugs market
Target Audiences for Benign Prostatic Hyperplasia (BPH) Drugs Market:
- Investors
- Investment Bankers
- Key Consulting Companies and Advisors
- Venture Capitalists
- Large, Medium-sized, and Small enterprises
Customization:
We also provide customized reports according to customer\'s specific requirements. We also provide customization for regional and country-level reports individually.
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
- Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
- Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
- Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
- Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
- Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.